176 related articles for article (PubMed ID: 36495058)
1. Metabolomic and transcriptomic studies of improvements in myocardial infarction due to Pycr1 deletion.
Xue Z; Pan Y; Kong X; Zhang J; Wu D; Zhou B
J Cell Mol Med; 2023 Jan; 27(1):89-100. PubMed ID: 36495058
[TBL] [Abstract][Full Text] [Related]
2. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
3. Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis.
Oudaert I; Satilmis H; Vlummens P; De Brouwer W; Maes A; Hose D; De Bruyne E; Ghesquière B; Vanderkerken K; De Veirman K; Menu E
J Exp Clin Cancer Res; 2022 Feb; 41(1):45. PubMed ID: 35105345
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of Pycr1 and Pycr2 in mice.
Stum MG; Tadenev ALD; Seburn KL; Miers KE; Poon PP; McMaster CR; Robinson C; Kane C; Silva KA; Cliften PF; Sundberg JP; Reinholdt LG; John SWM; Burgess RW
Genetics; 2021 May; 218(1):. PubMed ID: 33734376
[TBL] [Abstract][Full Text] [Related]
5. Zebrafish Carrying
Liang ST; Audira G; Juniardi S; Chen JR; Lai YH; Du ZC; Lin DS; Hsiao CD
Cells; 2019 May; 8(5):. PubMed ID: 31091804
[TBL] [Abstract][Full Text] [Related]
6. Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers.
Ding J; Kuo ML; Su L; Xue L; Luh F; Zhang H; Wang J; Lin TG; Zhang K; Chu P; Zheng S; Liu X; Yen Y
Carcinogenesis; 2017 May; 38(5):519-531. PubMed ID: 28379297
[TBL] [Abstract][Full Text] [Related]
7. SIRT3 regulates cancer cell proliferation through deacetylation of PYCR1 in proline metabolism.
Chen S; Yang X; Yu M; Wang Z; Liu B; Liu M; Liu L; Ren M; Qi H; Zou J; Vucenik I; Zhu WG; Luo J
Neoplasia; 2019 Jul; 21(7):665-675. PubMed ID: 31108370
[TBL] [Abstract][Full Text] [Related]
8.
Christensen EM; Bogner AN; Vandekeere A; Tam GS; Patel SM; Becker DF; Fendt SM; Tanner JJ
J Biol Chem; 2020 Dec; 295(52):18316-18327. PubMed ID: 33109600
[TBL] [Abstract][Full Text] [Related]
9. PYCR in Kidney Renal Papillary Cell Carcinoma: Expression, Prognosis, Gene Regulation Network, and Regulation Targets.
Shao Z; Lu L; Cui Y; Deng L; Xu Q; Liang Q; Lu X; Zhang J; Chen J; Situ Y
Front Biosci (Landmark Ed); 2022 Dec; 27(12):336. PubMed ID: 36624948
[TBL] [Abstract][Full Text] [Related]
10. Defect in proline synthesis: pyrroline-5-carboxylate reductase 1 deficiency leads to a complex clinical phenotype with collagen and elastin abnormalities.
Kretz R; Bozorgmehr B; Kariminejad MH; Rohrbach M; Hausser I; Baumer A; Baumgartner M; Giunta C; Kariminejad A; Häberle J
J Inherit Metab Dis; 2011 Jun; 34(3):731-9. PubMed ID: 21487760
[TBL] [Abstract][Full Text] [Related]
11. Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1.
Christensen EM; Patel SM; Korasick DA; Campbell AC; Krause KL; Becker DF; Tanner JJ
J Biol Chem; 2017 Apr; 292(17):7233-7243. PubMed ID: 28258219
[TBL] [Abstract][Full Text] [Related]
12. Human pyrroline-5-carboxylate reductase (PYCR1) acts on Δ(1)-piperideine-6-carboxylate generating L-pipecolic acid.
Struys EA; Jansen EE; Salomons GS
J Inherit Metab Dis; 2014 May; 37(3):327-32. PubMed ID: 24431009
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modification facilitates proline synthase PYCR1 aberrant expression in gastric cancer.
Xiao S; Yao X; Ye J; Tian X; Yin Z; Zhou L
Biochim Biophys Acta Gene Regul Mech; 2022 Aug; 1865(6):194829. PubMed ID: 35654390
[TBL] [Abstract][Full Text] [Related]
14. Pyrroline-5-carboxylate reductase 1 (PYCR1) upregulation contributes to gastric cancer progression and indicates poor survival outcome.
Xiao S; Li S; Yuan Z; Zhou L
Ann Transl Med; 2020 Aug; 8(15):937. PubMed ID: 32953737
[TBL] [Abstract][Full Text] [Related]
15. Structure, biochemistry, and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase (PYCR), an emerging cancer therapy target.
Bogner AN; Stiers KM; Tanner JJ
Amino Acids; 2021 Dec; 53(12):1817-1834. PubMed ID: 34003320
[TBL] [Abstract][Full Text] [Related]
16. Kindlin-2 links mechano-environment to proline synthesis and tumor growth.
Guo L; Cui C; Zhang K; Wang J; Wang Y; Lu Y; Chen K; Yuan J; Xiao G; Tang B; Sun Y; Wu C
Nat Commun; 2019 Feb; 10(1):845. PubMed ID: 30783087
[TBL] [Abstract][Full Text] [Related]
17. Shikonin induces apoptosis and autophagy via downregulation of pyrroline-5-carboxylate reductase1 in hepatocellular carcinoma cells.
Zhang J; Shang L; Jiang W; Wu W
Bioengineered; 2022 Mar; 13(3):7904-7918. PubMed ID: 35293266
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the effects of PYCR1 on cell function and its associated mechanism in hepatocellular carcinoma.
Xu Y; Zuo W; Wang X; Zhang Q; Gan X; Tan N; Jia W; Liu J; Li Z; Zhou B; Zhao D; Xie Z; Tan Y; Zheng S; Liu C; Li H; Chen Z; Yang X; Huang Z
Int J Biol Sci; 2021; 17(9):2223-2239. PubMed ID: 34239351
[TBL] [Abstract][Full Text] [Related]
19. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
[TBL] [Abstract][Full Text] [Related]
20. DJ-1 cooperates with PYCR1 in cell protection against oxidative stress.
Yasuda T; Kaji Y; Agatsuma T; Niki T; Arisawa M; Shuto S; Ariga H; Iguchi-Ariga SM
Biochem Biophys Res Commun; 2013 Jun; 436(2):289-94. PubMed ID: 23743200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
